InsiderTrades

Form 4 for STRO SUTRO BIOPHARMA, INC.

Accepted 2022-02-09 00:00:00 ET · period of report 2022-02-08 · accession 0001209191-22-008198 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2022-02-09 2022-02-08 STRO Petree Daniel H Dir M - OptEx $5.08 +14.3K 12.5K New +$72.6K
DM 2022-02-09 2022-02-08 STRO Petree Daniel H Dir M - OptEx $0.00 -14.3K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-02-08 M A 3,540 $5.81 22,265 D — —
2 Common Common Stock 2022-02-08 M A 2,124 $5.81 18,725 D — —
3 Common Common Stock 2022-02-08 M A 873 $5.81 16,601 D — —
4 Common Common Stock 2022-02-08 M A 578 $5.81 15,728 D — —
5 Common Common Stock 2022-02-08 M A 2,617 $4.36 15,150 D — —
6 Common Common Stock 2022-02-08 M A 4,545 $4.36 12,533 D — —
7 Derivative Stock Option 2022-02-08 M D 3,540 $0.00 0 D $5.81 · — to 2024-02-26 3,540 Common Stock (F2) The option is fully vested and exercisable.
8 Derivative Stock Option 2022-02-08 M D 2,124 $0.00 0 D $5.81 · — to 2024-02-26 2,124 Common Stock (F2) The option is fully vested and exercisable.
9 Derivative Stock Option (right to buy) 2022-02-08 M D 873 $0.00 0 D $5.81 · — to 2023-02-13 873 Common Stock (F2) The option is fully vested and exercisable.
10 Derivative Stock Option (right to buy) 2022-02-08 M D 2,617 $0.00 0 D $4.36 · — to 2022-09-19 2,617 Common Stock (F2) The option is fully vested and exercisable.
11 Derivative Stock Option (right to buy) 2022-02-08 M D 4,545 $0.00 0 D $4.36 · — to 2022-04-17 4,545 Common Stock (F2) The option is fully vested and exercisable.
12 Derivative Stock Option (right to buy) 2022-02-08 M D 578 $0.00 0 D $5.81 · — to 2023-02-13 578 Common Stock (F2) The option is fully vested and exercisable.